CN108273051B - The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine - Google Patents

The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine Download PDF

Info

Publication number
CN108273051B
CN108273051B CN201810105934.XA CN201810105934A CN108273051B CN 108273051 B CN108273051 B CN 108273051B CN 201810105934 A CN201810105934 A CN 201810105934A CN 108273051 B CN108273051 B CN 108273051B
Authority
CN
China
Prior art keywords
preparation
inactivated
solution
vaccine
perfringens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810105934.XA
Other languages
Chinese (zh)
Other versions
CN108273051A (en
Inventor
杨耀光
张俊清
郝俊飞
屈建平
杨耀军
黄建华
邵春华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORDOS XUHE ANIMAL HUSBANDRY Co Ltd
Original Assignee
ORDOS XUHE ANIMAL HUSBANDRY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORDOS XUHE ANIMAL HUSBANDRY Co Ltd filed Critical ORDOS XUHE ANIMAL HUSBANDRY Co Ltd
Priority to CN201810105934.XA priority Critical patent/CN108273051B/en
Publication of CN108273051A publication Critical patent/CN108273051A/en
Application granted granted Critical
Publication of CN108273051B publication Critical patent/CN108273051B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention belongs to veterinary biologics technical fields, are related to the rapidly and efficiently preparation method of a boar A type C.perfringens inactivated vaccine.The following steps are included: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scrapes intestinal contents, refrigeration or freezing;By culture medium, high pressure sterilization passes on 3 times until pathological material of disease is poured into pressure cooker, Anaerobic culturel after temperature reduces in pressure cooker;It takes the bacterium solution passed on three times to access the membrane digestion soup culture of meat liver stomach, is centrifuged after culture, takes supernatant;Inactivator is added to supernatant, shake well inactivates detoxification, obtains inactivated bacterial liquid;Inactivated bacterial liquid is mixed with adjuvant, obtains inactivated vaccine.Method and process provided by the invention is simple, at low cost, pollution is small, and the inactivated vaccine prepared is highly-safe, has no adverse reaction after injection, and immune efficacy is high, duration of immunity is long.

Description

The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine
Technical field
The invention belongs to veterinary biologics technical fields, and in particular to a boar A type C.perfringens inactivated vaccine Rapidly and efficiently preparation method.
Background technique
C.perfringens is also known as clostridieum welchii, can produce a variety of exotoxins and enzyme, can decompose muscle and connective tissue In sugar, generate bulk gas, lead to the serious wind-puff of tissue, then influence blood supply, cause tissue large area downright bad.According to The synthesized primary toxins secreted of C.perfringens, are divided into five kinds of toxin types of A, B, C, D, E;Wherein A type C.perfringens Mainly cause the lesion of gastrointestinal tract, is people and animals' gas gangrene, rabbit clostridium property diarrhea, horse necrotic enteritis and people's food poisoning Main pathogenic bacteria, and cause the main pathogenic bacteria of deer hemorrhagic enteritis.It is most important in a variety of exotoxins that the type bacterium generates It is alpha toxin.Pig A type C.perfringens is the main reason for causing piglet, growing and fattening pigs, farrowing sow and boar " sudden death ", Characterized by enterotoxemia and necrotic enteritis caused by the gastrointestinal tract diffusivity bleeding, morbidity is anxious, and the course of disease is short, without any early period Sign and die by visitation of God.
Currently, C.perfringens inactivated vaccine also has more research, Chinese patent application CN102698259A is public A kind of chicken necrotizing enterocolitis (A type) inactivated vaccine preparation method is opened, by CVCC37 plants of seed liquors of A type C.perfringens by training The 1%-2% for supporting base total amount is inoculated in using pancreas casein peptone and yeast extract powder as the liquid synthetic media of main raw material(s) In, 37 DEG C of anaerobic fermentation cultures/or stationary culture 6 hours, culture terminate after through 3000r/min centrifugation 30min removal thallus, point System is not concentrated by ultrafiltration with the millipore of 8Ku molecular cut off to be concentrated by ultrafiltration, is inactivated through 0.6% formalin de- After poison is complete, 20% volume aluminium hydroxide of final concentration is added and is configured to vaccine.Chinese patent application CN104623651A discloses one The preparation method of the A type C.perfringens inactivated vaccine of kind rabbit clostridium welchii disease, this method are with A type C.perfringens Original strain finally obtains bacterium solution after firsts and seconds culture, which is mixed with white-oil adjuvant and obtains A type production gas Capsular clostridium inactivated vaccine;Wherein, inactivator used is the formaldehyde that final mass score is 0.3%, and adjuvant is white-oil adjuvant.It is bent (the safety of [1] Qu Haibo, Liu Hongbin, Bai Tongchen .A type C.perfringens toxoid vaccine and full bacterium inactivated vaccine such as hypo Property and immune efficacy comparative studies [J] China veterinary drug magazine, 2010,44 (02): 15-16.) have studied the six batches of rabbit A types and produce gas Capsular clostridium toxoid vaccine and its full bacterium inactivated vaccine, and research is compared to its safety and immune efficacy;Knot Fruit shows that toxoid inactivated vaccine has no toxic side effect, and local stimulation is small, and safety is better than full inactivated vaccine, immune efficacy result The malicious protective rate of attacking of the two no significant difference, two kinds of vaccines is not less than 4/5, and duration of immunity is at 6 months or more;Wherein inactivator Using 0.4% formalin, adjuvant uses aluminium hydroxide gel.
Currently, the livestock that the research of A type C.perfringens inactivated vaccine is directed to is mostly deer, rabbit, ox, for pig A type pod The research of film clostridium inactivated vaccine is less, and simply replacement can not obtain that safety is good, stability is high, good immune effect Pig vaccine, and for the inactivation reagent of C.perfringens using the formaldehyde for having carcinogenic effect, adjuvant is more in the prior art Using the aluminium hydroxide gel containing heavy metal.These vaccines still have some needs in use and further solve the problems, such as: (1) Domestic animal reaction of inoculation is heavier;(2) injection dosage is big, and using there is inconvenient (3) preparation process cumbersome, the time is longer more.Therefore, it is necessary to Preparation process and screening and culturing medium and adjuvant are improved, quickly to prepare efficient vaccine, to improve vaccine immunogenicity sum aggregate Body immune response is horizontal.
Summary of the invention
The technical problem to be solved by the present invention is in view of the foregoing drawbacks, provide pig A type C.perfringens inactivated vaccine Rapidly and efficiently preparation method.This method is simple and feasible, easy to operate, at low cost, pollution is small, the inactivated vaccine safety prepared Property it is high, have no adverse reaction after injection, immune efficacy is high, duration of immunity is long.
To achieve the goals above, the present invention adopts the following technical scheme:
The rapidly and efficiently preparation method of one boar A type C.perfringens inactivated vaccine, comprising the following steps:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens scrapes intestinal contents, refrigeration Or freezing;
(2) Spawn incubation: by culture medium in pressure cooker high pressure sterilization, until temperature reduce after, pathological material of disease is poured into high pressure In pot, Anaerobic culturel is passed on 3 times, and wherein culture medium is the synthetic media of plain chocolate and glucose;
(3) prepared by bacterium solution: taking the bacterium solution passed on three times in step (2) to access the membrane digestion soup culture of meat liver stomach, culture terminates After be centrifuged, take supernatant;
(4) bacterium solution inactivates: inactivator is added to the bacterium solution of step (3), shake well inactivates detoxification, obtains inactivated bacterial liquid, Middle inactivator is binary ethylenimine and beta-propiolactone;
(5) vaccine preparation: inactivated bacterial liquid is mixed with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant is multiple for immunostimulation Close object.
The selection of cause of disease is related to the biological efficacy of vaccine, and it is cause of disease that the application, which directly scrapes intestinal contents, can be with The problems such as vigor decline for avoiding preservation of bacteria strain from being likely to occur, toxicity decline, inhibit and kill other intestines under high-temperature and high-pressure conditions Road pathogen;A type C.perfringens mass propagation produces acid and produces gas, ensure that the purity and concentration of A type C.perfringens.
Culture medium is the artificial nutriment of bacterium, and different according to bacterium require by artificial means to prepare various nutriment one Rising becomes the basis maintained with bacterial growth, prepares applicable culture medium, nutriment needed for providing bacterium and growth conditions, The rule for understanding its growth and breeding, can be improved the quality and quantity of vaccine.The application is synthesized using plain chocolate and glucose Culture medium passes on 3 times, obtains pure culture;Strain after purification is digested into amplification cultivation in soup in pancreatin again, using meat liver stomach film Soup is digested to cultivate, and the virulence for the A type clostridium which turns out is high compared to the virulence of ordinary culture medium culture, vaccine quality It is good.
Inactivator is the chemical reagent or drug for inactivating microorganism, is a very important skill in biological products Art, for improving the safety of biological products and preventing pathogen from spreading.Common inactivator is formaldehyde, but formaldehyde is a kind of The carcinogen of intense irritation both may act on the amino-containing nucleotide base (such as A, G, U) of virus, and can operational virus Glutelin.When acting on virus coat protein, easily make protein crosslink or virion aggregation, can no longer function to glutelin Interior nucleic acid.In this way, the antigenicity of pathogen protein can be seriously damaged, and there may be pathogen survival;Use formalin-inactivated Time is long, and inactivate effect vulnerable to temperature, pH, concentration, with the presence or absence of organic matter, the type of pathogen and nitrogen content etc. because Element influences, and should arouse attention under study for action;Remaining free formaldehyde, if after injecting body with vaccine, the system that can generate swashs property reaction. Using binary ethylenimine and beta-propiolactone as inactivator in the application, binary ethylenimine mainly acts on nucleic acid, protein immunization Antigen is kept preferably, and small toxicity, but the virus stability inactivated is poor, and the validity period of vaccine is short;Beta-propiolactone directly with disease Malicious nucleic acid effect, without acting on glutelin, is able to maintain immunogenicity, has strong inactivating efficacy, and inactivation time is short, pole Facile hydrolysis, it is not necessary to consider residual of the finished product in vaccine, although there is many advantages, beta-propiolactone is a kind of potential carcinogenic The factor, and the holding time it is too long cause self-polymerization influence inactivating efficacy.Binary ethylenimine and beta-propiolactone are collectively as going out Agent living can act synergistically, and superiority and inferiority is complementary, not only shorten inactivation time, improve inactivation effect, further improve the peace of vaccine Quan Xing maintains the immunogenicity of virus.
Adjuvant is the substance that antigen-specific immune response can be enhanced.The faint object of antigenicity can be remarkably reinforced in adjuvant Matter induces body to generate specific immune response, and can use the smallest antigen and least inoculation times, generates enough Immune response.Common adjuvant is aluminium hydroxide gel, but vaccine injection amount made of aluminium hydroxide gel is big, when immunity continues Between it is short, domestic animal reaction weight, subcutaneous injection often has swelling or an agglomeration;The application, as adjuvant, is immunized using immunostimulating complex Stimulation compound (ISCOM) is made of saponin(e, grease, cholesterol and antigen, passes through the hydrophobic effect between preceding 3 components It is combined together.Hydrophobic or hydrophilic antigen can be incorporated on its compound, and compared with other adjuvants, ISCOM is safer, It is capable of forming long acting biologically active reaction, the dual function offered with adjuvant and antigen.
Further, in above-mentioned steps (1), refrigerated storage temperature is 2-5 DEG C, and cryogenic temperature is -20 DEG C.
Further, in above-mentioned steps (2), pressure cooker sterilising temp is 110 DEG C, sterilization time 20min;Until temperature drops To after 80 DEG C, pathological material of disease is poured into pressure cooker, 42-45 DEG C of high temperature anaerobic culture 4-6h is passed on.The application selection adds at 80 ° This bold improvement of pathological material of disease had not only killed unrelated pathogen but also had shortened the time of germ isolation and purification culture, greatly shortened Vaccine production time.
Further, in above-mentioned steps (3), the bacterium solution passed on three times in step (2) is taken to access 37 DEG C of soup of meat liver stomach membrane digestion 6-10h is cultivated, 10-15min is centrifuged in 4000-6000r/min after culture, takes supernatant.
Further, meat liver stomach membrane digestion soup ingredient include: hog gastric mucosa, beef, beef liver, hydrochloric acid, sodium hydroxide, go from Sub- water and ethyl alcohol.
According to one embodiment of the application, meat liver stomach membrane digestion soup ingredient include: hog gastric mucosa 150g, beef 100g, Beef liver 100g, hydrochloric acid 10mL, sodium hydroxide 6g, deionized water 1000mL and ethyl alcohol 100mL.
Further, the preparation of meat liver stomach membrane digestion soup adds the following steps are included: beef, beef liver, hog gastric mucosa are blended Enter distilled water, hydrochloric acid and ethyl alcohol, after mixing cold soaking 20-24h, is slowly heated to temperature 56 ± 1 DEG C of holdings 22-24h, every 1h Stirring is primary, removes oil slick rouge, digestive juice is taken to boil, and with 2mol/L sodium hydroxide solution tune pH value, flannelette filtering takes supernatant 116 DEG C of sterilizing 30min are spare.
Further, in above-mentioned steps (4), it is molten that the binary ethylenimine that mass fraction is 0.2% is added to the bacterium solution of step (3) Liquid makes its final mass score 0.02-0.05%, and mixed liquor is inactivated 20-24h in 20-30 DEG C of concussion, is added in β-the third afterwards Ester makes its final concentration of 1g/L, inactivates 2h in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, makes its final concentration It is consistent with binary ethylenimine, inactivation 1h is terminated, inactivated bacterial liquid is obtained.
Further, in above-mentioned steps (5), the preparation of immunostimulating complex the following steps are included:
1) preparation of lipid mixture solution: lecithin and cholesterol are added in 20%Mega-10, make the two final concentration It is all 10mg/mL;
2) preparation of saponin(e solution: QS-21 being dissolved in the PBS solution that pH is 7.2, and adjustment concentration is 10-15mg/ mL。
3) prepared by immunostimulating complex: being by volume 1:(3-5 by lipid mixture solution and saponin(e solution) sufficiently 5-7h is cracked under mixed room temperature;Ice-bath ultrasonic process, dialysis save backup after crossing 0.22 μm of filter membrane degerming in 4 DEG C.
Further, in above-mentioned steps (5), the volume ratio of inactivated bacterial liquid and adjuvant is 1:(2-4).
According to one embodiment of the application, the rapidly and efficiently side of preparation of a boar A type C.perfringens inactivated vaccine Method, comprising the following steps:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scraping intestinal contents, 2 DEG C Refrigeration;
(2) Spawn incubation: by culture medium, high pressure sterilization, sterilising temp are 110 DEG C in pressure cooker, and sterilization time is 20min;Until temperature is reduced to 80 DEG C, pathological material of disease is poured into pressure cooker, 44 DEG C of high temperature anaerobic culture 4h are passed on, passage 3 Secondary, wherein culture medium is the synthetic media of plain chocolate and glucose;
(3) prepared by bacterium solution: the bacterium solution passed on three times in step (2) being taken to access 37 DEG C of culture 8h of meat liver stomach membrane digestion soup, training It is centrifuged 10min in 6000r/min after supporting, takes supernatant;Wherein, meat liver stomach membrane digestion soup preparation the following steps are included: Beef 100g, beef liver 100g, hog gastric mucosa 150g are blended, distilled water 1000mL, hydrochloric acid 10mL and ethyl alcohol 100mL is added, is mixed Cold soaking 20h after closing uniformly is slowly heated to 56 DEG C of temperature and keeps for 24 hours, and every 1h stirring is primary, removes oil slick rouge, digestive juice is taken to boil Boiling, with 2mol/L sodium hydroxide solution 75mL tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes it most Whole mass fraction is 0.04%, and mixed liquor is inactivated 20h in 30 DEG C of concussions, and the rear beta-propiolactone that is added makes its final concentration of 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, keeps its final concentration consistent with binary ethylenimine, eventually 1h is only inactivated, inactivated bacterial liquid is obtained.
(5) vaccine preparation: by inactivated bacterial liquid, 1:3 is mixed by volume with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant For immunostimulating complex;Wherein, immunostimulating complex preparation the following steps are included:
1) preparation of lipid mixture solution: lecithin and cholesterol are added in 20%Mega-10, make the two final concentration It is all 10mg/mL;
2) preparation of saponin(e solution: QS-21 being dissolved in the PBS solution that pH is 7.2, and adjustment concentration is 12mg/mL.
3) prepared by immunostimulating complex: lipid mixture solution and saponin(e solution are sufficiently mixed by volume for 1:5 7h is cracked at room temperature;Ice-bath ultrasonic process, dialysis save backup after crossing 0.22 μm of filter membrane degerming in 4 DEG C.
It is a further object to provide a kind of pig A types being prepared according to any of the above-described preparation method to produce gas pod Film clostridium inactivated vaccine.
Beneficial effects of the present invention:
(1) directly scraping intestinal contents are cause of disease, inhibit and kill other enteric pathogenic bacterias under high-temperature and high-pressure conditions;A Type C.perfringens mass propagation produces acid and produces gas, ensure that the purity and concentration of A type C.perfringens.80 degree plus pathological material of disease this One bold improvement had not only killed unrelated pathogen but also had shortened the time of germ isolation and purification culture, and substantially reduced vaccine Production Time.
(2) using milk as culture medium Rapid Fermentation separating-purifying strain, meat liver stomach membrane digestion soup is as amplification culture medium, training The virulence of the A type clostridium raised is high compared to the virulence of ordinary culture medium culture, and vaccine is high-quality.
(3) effect that inactivation is largely improved using alkylating agent and beta-propiolactone synergistic effect, when shortening inactivation Between, improve the safety of vaccine.
(4) vaccine includes the mycoprotein of inactivation, endotoxin and exotoxin, and immunogenicity is good, and protective rate is high.
(5) immune efficacy of vaccine is high, and the immunity duration is long.
(6) allergic reaction is small, does not influence spirit, appetite, injection site is without swelling, no necrosis.
(7) simple process, time are short, low in cost.
Specific embodiment
The present invention is further elaborated with reference to embodiments.These embodiments be only for illustrative purposes, And do not limit the scope of the invention and essence.Based on the embodiment of the present invention, those of ordinary skill in the art are not making wound Every other embodiment obtained under the premise of the property made labour, belongs to protection scope of the present invention.
Embodiment 1
The rapidly and efficiently preparation method of one boar A type C.perfringens inactivated vaccine:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scraping intestinal contents, 2 DEG C Refrigeration;
(2) Spawn incubation: by the synthetic media of plain chocolate and glucose, high pressure sterilization, sterilising temp are in pressure cooker 110 DEG C, sterilization time 20min;Until temperature is reduced to 80 DEG C, pathological material of disease is poured into pressure cooker, 44 DEG C of high temperature anaerobic cultures 4h is passed on, and is passed on 3 times;
(3) prepared by bacterium solution: the bacterium solution passed on three times in step (2) being taken to access 37 DEG C of culture 8h of meat liver stomach membrane digestion soup, training It is centrifuged 10min in 6000r/min after supporting, takes supernatant;Wherein, meat liver stomach membrane digestion soup preparation the following steps are included: Beef 100g, beef liver 100g, hog gastric mucosa 150g are blended, distilled water 1000mL, hydrochloric acid 10mL and ethyl alcohol 100mL is added, is mixed Cold soaking 20h after closing uniformly is slowly heated to 56 DEG C of temperature and keeps for 24 hours, and every 1h stirring is primary, removes oil slick rouge, digestive juice is taken to boil Boiling, with 2mol/L sodium hydroxide solution 75mL tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes it most Whole mass fraction is 0.04%, and mixed liquor is inactivated 20h in 30 DEG C of concussions, and the rear beta-propiolactone that is added makes its final concentration of 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, keeps its final concentration consistent with binary ethylenimine, eventually 1h is only inactivated, inactivated bacterial liquid is obtained.
(5) vaccine preparation: by inactivated bacterial liquid, 1:3 is mixed by volume with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant For immunostimulating complex, the preparation method comprises the following steps: the 1) preparation of lipid mixture solution: lecithin and cholesterol are added to 20% In Mega-10, making the two final concentration is all 10mg/mL;2) QS-21 the preparation of saponin(e solution: is dissolved in the PBS that pH is 7.2 In solution, adjustment concentration is 12mg/mL.3) prepared by immunostimulating complex: lipid mixture solution and saponin(e solution are pressed body Product cracks 7h than being sufficiently mixed for 1:5 at room temperature;Ice-bath ultrasonic process, dialysis are standby in 4 DEG C of preservations after 0.22 μm of filter membrane degerming excessively With.
Embodiment 2
The rapidly and efficiently preparation method of one boar A type C.perfringens inactivated vaccine:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scraping intestinal contents, 5 DEG C Refrigeration;
(2) Spawn incubation: by the synthetic media of plain chocolate and glucose, high pressure sterilization, sterilising temp are in pressure cooker 110 DEG C, sterilization time 20min;Until temperature is reduced to 80 DEG C, pathological material of disease is poured into pressure cooker, 45 DEG C of high temperature anaerobic cultures 4h is passed on, and is passed on 3 times;
(3) prepared by bacterium solution: the bacterium solution passed on three times in step (2) being taken to access 37 DEG C of culture 10h of meat liver stomach membrane digestion soup, training It is centrifuged 15min in 6000r/min after supporting, takes supernatant;Wherein, meat liver stomach membrane digestion soup preparation the following steps are included: Beef 100g, beef liver 100g, hog gastric mucosa 150g are blended, distilled water 1000mL, hydrochloric acid 10mL and ethyl alcohol 100mL is added, is mixed Cold soaking for 24 hours, is slowly heated to 57 DEG C of temperature and keeps for 24 hours after closing uniformly, and every 1h stirring is primary, removes oil slick rouge, digestive juice is taken to boil Boiling, with 2mol/L sodium hydroxide solution 75mL tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes it most Whole mass fraction is 0.05%, and mixed liquor is inactivated 20h in 30 DEG C of concussions, and the rear beta-propiolactone that is added makes its final concentration of 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, keeps its final concentration consistent with binary ethylenimine, eventually 1h is only inactivated, inactivated bacterial liquid is obtained.
(5) vaccine preparation: by inactivated bacterial liquid, 1:4 is mixed by volume with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant For immunostimulating complex, the preparation method comprises the following steps: the 1) preparation of lipid mixture solution: lecithin and cholesterol are added to 20% In Mega-10, making the two final concentration is all 10mg/mL;2) QS-21 the preparation of saponin(e solution: is dissolved in the PBS that pH is 7.2 In solution, adjustment concentration is 15mg/mL.3) prepared by immunostimulating complex: lipid mixture solution and saponin(e solution are pressed body Product cracks 7h than being sufficiently mixed for 1:5 at room temperature;Ice-bath ultrasonic process, dialysis are standby in 4 DEG C of preservations after 0.22 μm of filter membrane degerming excessively With.
Embodiment 3
The rapidly and efficiently preparation method of one boar A type C.perfringens inactivated vaccine:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scraping intestinal contents, 4 DEG C Refrigeration;
(2) Spawn incubation: by the synthetic media of plain chocolate and glucose, high pressure sterilization, sterilising temp are in pressure cooker 110 DEG C, sterilization time 20min;Until temperature is reduced to 80 DEG C, pathological material of disease is poured into pressure cooker, 42 DEG C of high temperature anaerobic cultures 6h is passed on, and is passed on 3 times;
(3) prepared by bacterium solution: the bacterium solution passed on three times in step (2) being taken to access 37 DEG C of culture 6h of meat liver stomach membrane digestion soup, training It is centrifuged 10min in 4000r/min after supporting, takes supernatant;Wherein, meat liver stomach membrane digestion soup preparation the following steps are included: Beef 100g, beef liver 100g, hog gastric mucosa 150g are blended, distilled water 1000mL, hydrochloric acid 10mL and ethyl alcohol 100mL is added, is mixed Cold soaking 20h after closing uniformly is slowly heated to 55 DEG C of holding 22h of temperature, and every 1h stirring is primary, removes oil slick rouge, digestive juice is taken to boil Boiling, with 2mol/L sodium hydroxide solution 75mL tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes it most Whole mass fraction is 0.02%, and mixed liquor is inactivated for 24 hours in 20 DEG C of concussions, and the rear beta-propiolactone that is added makes its final concentration of 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, keeps its final concentration consistent with binary ethylenimine, eventually 1h is only inactivated, inactivated bacterial liquid is obtained.
(5) vaccine preparation: by inactivated bacterial liquid, 1:2 is mixed by volume with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant For immunostimulating complex, the preparation method comprises the following steps: the 1) preparation of lipid mixture solution: lecithin and cholesterol are added to 20% In Mega-10, making the two final concentration is all 10mg/mL;2) QS-21 the preparation of saponin(e solution: is dissolved in the PBS that pH is 7.2 In solution, adjustment concentration is 10mg/mL.3) prepared by immunostimulating complex: lipid mixture solution and saponin(e solution are pressed body Product cracks 5h than being sufficiently mixed for 1:3 at room temperature;Ice-bath ultrasonic process, dialysis are standby in 4 DEG C of preservations after 0.22 μm of filter membrane degerming excessively With.
Embodiment 4
The rapidly and efficiently preparation method of one boar A type C.perfringens inactivated vaccine:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens, scraping intestinal contents, 4 DEG C Refrigeration;
(2) Spawn incubation: by the synthetic media of plain chocolate and glucose, high pressure sterilization, sterilising temp are in pressure cooker 110 DEG C, sterilization time 20min;Until temperature is reduced to 80 DEG C, pathological material of disease is poured into pressure cooker, 43 DEG C of high temperature anaerobic cultures 5h is passed on, and is passed on 3 times;
(3) prepared by bacterium solution: the bacterium solution passed on three times in step (2) being taken to access 37 DEG C of culture 8h of meat liver stomach membrane digestion soup, training It is centrifuged 12min in 5000r/min after supporting, takes supernatant;Wherein, meat liver stomach membrane digestion soup preparation the following steps are included: Beef 100g, beef liver 100g, hog gastric mucosa 150g are blended, distilled water 1000mL, hydrochloric acid 10mL and ethyl alcohol 100mL is added, is mixed Cold soaking 22h after closing uniformly is slowly heated to 56 DEG C of holding 22h of temperature, and every 1h stirring is primary, removes oil slick rouge, digestive juice is taken to boil Boiling, with 2mol/L sodium hydroxide solution 75mL tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes it most Whole mass fraction is 0.04%, and mixed liquor is inactivated 23h in 25 DEG C of concussions, and the rear beta-propiolactone that is added makes its final concentration of 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, keeps its final concentration consistent with binary ethylenimine, eventually 1h is only inactivated, inactivated bacterial liquid is obtained.
(5) vaccine preparation: by inactivated bacterial liquid, 1:3 is mixed by volume with adjuvant, obtains inactivated vaccine;Wherein, the adjuvant For immunostimulating complex, the preparation method comprises the following steps: the 1) preparation of lipid mixture solution: lecithin and cholesterol are added to 20% In Mega-10, making the two final concentration is all 10mg/mL;2) QS-21 the preparation of saponin(e solution: is dissolved in the PBS that pH is 7.2 In solution, adjustment concentration is 12mg/mL.3) prepared by immunostimulating complex: lipid mixture solution and saponin(e solution are pressed body Product cracks 6h than being sufficiently mixed for 1:3 at room temperature;Ice-bath ultrasonic process, dialysis are standby in 4 DEG C of preservations after 0.22 μm of filter membrane degerming excessively With.
Comparative example 1
The bacterium solution inactivation process of 1 step of embodiment (4) is changed to: formalin is added to the bacterium solution of step (3), makes formaldehyde Final mass score be 0.4%, 37 DEG C inactivation detoxification 3 days, obtain inactivated bacterial liquid;
Embodiment 5
Inactivated bacterial liquid, the untreated pig A type that inactivated bacterial liquid that 1 step of embodiment (4) obtains, comparative example 1 are obtained produce Gas capsular clostridium virus, the mixed liquor without viral 1 inactivator of culture medium and embodiment, the culture medium without virus and comparison The mixed liquor of 1 inactivator of example is inoculated into the ST cell of health, and does blank control (not being inoculated with), and blind passage to the third generation is observed Cytopathy.Cell state is observed, as a result, it has been found that, inactivated bacterial liquid, the comparative example 1 that inoculation 1 step of embodiment (4) obtains obtain Inactivated bacterial liquid, the mixed liquor without viral 1 inactivator of culture medium and embodiment, the culture medium without virus and comparative example 1 are gone out The cell quantity of the mixed liquor of agent living is consistent with blank control group, meets normal cell growth state, for lesion occurs;And it is inoculated with The cell whole lesion of untreated pig A type clostridium perfringens disease poison.
Embodiment 6
The sterility test of pig A type C.perfringens inactivated vaccine
Steriling test is tested by method as defined in " Chinese veterinary pharmacopoeia ", equal asepsis growth.
Embodiment 7
The security inspection of pig A type C.perfringens inactivated vaccine
(1) the minimum safety testing for using the single dose vaccine inoculation of age in days pig
Susceptible pig 20 of 30 ages in days health is taken, is randomly divided into 4 groups, 5/group.Preceding 3 groups of difference neck intramuscular injection embodiment The vaccine (the 1st batch, the 2nd batch and the 3rd batch) of 3 batches of the 1 method preparation provided, 2ml/ is only;4th group be not inoculated with as pair According to.It raises, observes 10 under the same terms, it is daily to observe whether dog spirit, diet, excrement are normal, and injection site and whole body have It has no adverse reaction.
The result shows that the pig state of mind, diet, excrement are normal after single dose of intramuscular injection, injection site and Whole body has no adverse reaction, and all pigs are strong to live.
(2) safety testing of single dose repeated inoculation vaccine
Susceptible pig 20 of 30 ages in days health is taken, is randomly divided into 4 groups, 5/group.Preceding 3 groups of difference intramuscular inoculations are according to embodiment The vaccine of 3 batches of 1 method preparation, only, booster immunization is primary after 14 days by 2ml/, and 2ml/ is only;4th group be not inoculated with as pair According to.It raises, observes 10 under the same terms, it is daily to observe whether pig spirit, diet, excrement are normal, and injection site and whole body have It has no adverse reaction.
The result shows that the pig state of mind, diet, excrement are normal, injection site after intramuscular routes repeated inoculation vaccine And whole body has no adverse reaction, all pigs are strong to live.
The safety testing of (3) overdose vaccine inoculations
Susceptible pig 20 of 30 ages in days health is taken, is randomly divided into 4 groups, 5/group.Preceding 3 groups of difference intramuscular inoculations are according to embodiment 3 batch vaccines of 1 preparation, 6ml/ is only;4th group is not inoculated with as control.It raises, observes 10 under the same terms, it is daily to see Examine whether pig spirit, diet, excrement are normal, and injection site and whole body have no adverse reaction.
The result shows that the pig state of mind, diet, excrement are normal, injection part after intramuscular routes overdose vaccine inoculation Position and whole body have no adverse reaction, and all pigs are strong to live.
(4) safety testing of the vaccine to farrowing sow
Vaccine is prepared according to 1 method of embodiment, is taken farrowing sow 10, is randomly divided into 2 groups, 5/group.1st group in antenatal Intramuscular inoculation vaccine on the 20th, 8ml/ is only;2nd group is not inoculated with as control.It raises, observes 10 under the same terms, it is daily to observe Whether pig spirit, diet, excrement normal, and injection site and whole body have no adverse reaction, and follow-up observation its farrow situation.
The result shows that farrowing sow in antenatal 20 age through muscle overdose inoculation after, the sow state of mind, diet, excrement Normal, injection site and whole body have no adverse reaction, and all pigs are strong to live, and it is normal to farrow.
Conclusion
Safety test, the single dose repeated inoculation of the inoculation of a single dose have been carried out with 3 batches of pig A type clostridieum welchii inactivated vaccines Safety testing, the inoculation of overdose safety test, be as a result safe.Show the vaccine for immunity inoculation pig It is safe.Above-mentioned test (1)-(4) have also been carried out to embodiment 2, embodiment 3, embodiment 4, the results showed that, which is used for Immunity inoculation pig is safe.
Embodiment 8
The potency test of pig A type C.perfringens inactivated vaccine
3 batches of pig A type clostridieum welchii inactivated vaccines of Example preparation take health susceptible pig 80, are randomly divided into 16 groups, 5/group.1,2,3 groups of pigs distinguish 3 batches of vaccines 2ml/ that intramuscular inoculations are prepared according to embodiment 1, and 4,5,6 groups of pigs distinguish muscle 3 batches of vaccines 2ml/ prepared according to embodiment 2 are inoculated with, 7,8,9 groups of pigs distinguish 3 batches that intramuscular inoculations are prepared according to embodiment 3 Only, 10,11,12 groups of pigs distinguish 3 batches of vaccines 2ml/ that intramuscular inoculations are prepared according to embodiment 4, control group 1,2,3 to vaccine 2ml/ 3 crowdes of vaccine 2ml/ made from the preparation method that group pig difference intramuscular inoculation is provided according to Chinese patent CN101708332A only, sky White group without immune.It is attacked respectively at 14 days, 30 days, 90 days, 120 days, 180 days, the culture solution 15ml living of oral clostridium on the 270th Poison is observed 10, and incidence is recorded.The results are shown in Table 1.
The potency test of 1 pig A type C.perfringens inactivated vaccine of table
Remarks: protective rate=key number/test number living
To sum up, the vaccine safety of the application preparation is good, and local irritation is small, and the adverse reactions such as no lump, granuloma go out It is existing;And immune efficacy is high, duration of immunity was long, up to 9 months or more;Efficacy test is carried out in duration of immunity, meets " Chinese veterinary drug Allusion quotation " quality standard.
The above description is only a preferred embodiment of the present invention, is not intended to limit the scope of the invention, all utilizations Equivalent structure or equivalent flow shift made by description of the invention is applied directly or indirectly in other relevant technology necks Domain is included within the scope of the present invention.

Claims (7)

1. the rapidly and efficiently preparation method of a boar A type C.perfringens inactivated vaccine, which is characterized in that step are as follows:
(1) acquisition of pathogen: the pathological material of disease of the lethal sick pig of picking A type C.perfringens scrapes intestinal contents, refrigeration or cold Freeze;
(2) Spawn incubation: by culture medium in pressure cooker high pressure sterilization, until temperature reduce after, pathological material of disease is poured into pressure cooker, Anaerobic culturel passes on 3 times, and wherein culture medium is the synthetic media of plain chocolate and glucose;
(3) bacterium solution prepare: take the bacterium solution passed on three times in step (2) access the membrane digestion soup culture of meat liver stomach, after culture from The heart takes supernatant;
(4) bacterium solution inactivates: the binary ethylenimine solution that mass fraction is 0.2%, which is added, to the bacterium solution of step (3) makes its final matter Amount score is 0.02-0.05%, mixed liquor is inactivated 20-24h in 20-30 DEG C of concussion, the rear beta-propiolactone that is added makes its final concentration For 1g/L, 2h is inactivated in 37 DEG C of concussions, the sterile hypo solution of 1mol/L is added, makes its final concentration and binary ethylenimine Unanimously, inactivation 1h is terminated, inactivated bacterial liquid is obtained;
(5) vaccine preparation: inactivated bacterial liquid is mixed with adjuvant, obtains inactivated vaccine;
Wherein, inactivated bacterial liquid and the volume ratio of adjuvant are 1:(2-4);
The adjuvant is immunostimulating complex;The preparation of the immunostimulating complex the following steps are included:
S1: the preparation of lipid mixture solution: lecithin and cholesterol are added in 20%Mega-10, make the two final concentration all For 10mg/mL;
S2: the preparation of saponin(e solution: QS-21 being dissolved in the PBS solution that pH is 7.2, and adjustment concentration is 10-15mg/mL;
S3: immunostimulating complex preparation: being 1:(3-5 by lipid mixture solution and saponin(e solution by volume) it is sufficiently mixed 5-7h is cracked at room temperature;Ice-bath ultrasonic process, dialysis save backup after crossing 0.22 μm of filter membrane degerming in 4 DEG C.
2. preparation method according to claim 1, which is characterized in that in the step (1), refrigerated storage temperature is 2-5 DEG C, cold Freezing temperature is -20 DEG C.
3. preparation method according to claim 1, which is characterized in that in the step (2), pressure cooker sterilising temp is 110 DEG C, sterilization time 20min;Until pathological material of disease is poured into pressure cooker after temperature drops to 80 DEG C, 42-45 DEG C of high temperature anaerobic training Feeding 4-6h is passed on.
4. preparation method according to claim 1, which is characterized in that in the step (3), take in step (2) and pass three times The bacterium solution in generation accesses 37 DEG C of culture 6-10h of meat liver stomach membrane digestion soup, is centrifuged 10- in 4000-6000r/min after culture 15min takes supernatant.
5. the preparation method according to claim 4, which is characterized in that the meat liver stomach membrane digestion soup ingredient includes: pig stomach Mucous membrane, beef, beef liver, hydrochloric acid, sodium hydroxide, deionized water, ethyl alcohol.
6. the preparation method according to claim 4, which is characterized in that the preparation of the meat liver stomach membrane digestion soup includes following Step: beef, beef liver, hog gastric mucosa are blended, and distilled water, hydrochloric acid and ethyl alcohol are added, after mixing cold soaking 20-24h, slowly 56 ± 1 DEG C of holding 22-24h of temperature are heated to, every 1h stirring is primary, removes oil slick rouge, takes digestive juice to boil, with 2mol/L hydrogen-oxygen Change sodium solution tune pH value, flannelette filtering takes 116 DEG C of sterilizing 30min of supernatant spare.
7. a kind of pig A type C.perfringens inactivated vaccine that -6 any preparation methods are prepared according to claim 1.
CN201810105934.XA 2018-02-02 2018-02-02 The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine Active CN108273051B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810105934.XA CN108273051B (en) 2018-02-02 2018-02-02 The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810105934.XA CN108273051B (en) 2018-02-02 2018-02-02 The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine

Publications (2)

Publication Number Publication Date
CN108273051A CN108273051A (en) 2018-07-13
CN108273051B true CN108273051B (en) 2019-02-22

Family

ID=62807408

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810105934.XA Active CN108273051B (en) 2018-02-02 2018-02-02 The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine

Country Status (1)

Country Link
CN (1) CN108273051B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943507B (en) * 2019-03-26 2021-08-17 中国兽医药品监察所 Preparation method and application of veterinary A-type clostridium perfringens toxin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101695568A (en) * 2009-10-23 2010-04-21 王靖 A-type clostridium perfringens populus skin lipoid inactivated vaccine and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103721254A (en) * 2013-12-31 2014-04-16 鄂尔多斯市旭和畜牧有限责任公司 Method for preparing swine A-type clostridium perfringens aluminum hydroxide inactivated vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101695568A (en) * 2009-10-23 2010-04-21 王靖 A-type clostridium perfringens populus skin lipoid inactivated vaccine and preparation method thereof

Also Published As

Publication number Publication date
CN108273051A (en) 2018-07-13

Similar Documents

Publication Publication Date Title
JP4026722B2 (en) Fermented plant extract, fermented plant powder and blended plant extract
CN102168073B (en) Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
CN101144062B (en) Lactobacillus casei strain and application for products thereof in bird immunity
CN108342434B (en) Veterinary clostridium putrefaction toxin, preparation method thereof and special culture medium
JP2571158B2 (en) Introduction of bacteria into eggs
CN102058880B (en) Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia
CN109666609A (en) A kind of Rhodococcus ruber fermentation process and its application as adjuvant in animal vaccine
CN102626516A (en) Pseudomonas aeruginosa and propolis inactivated vaccine for minks and preparation process
CN102406925A (en) Preparation method of chicken infectious rhinitis and mycoplasma gallisepticum bivalent lipid inactivated vaccine
CN107299070B (en) D-type clostridium perfringens toxin for livestock and preparation method and special culture medium thereof
CN108721616B (en) A kind of avian pasteurella multocida capsular polysaccharide-protein conjugate vaccines and preparation method thereof
CN102406934A (en) Preparation method of chicken infectious rhinitis lipid inactivated vaccine
CN105106946B (en) A kind of cattle and sheep foot rot oil emulsion vaccine and preparation method thereof
CN108273051B (en) The rapidly and efficiently preparation method of pig A type C.perfringens inactivated vaccine
CN104031971B (en) A kind of free cell fermentation method production N-carbamylglutamic acid and its method for metabolite application
CN105148262B (en) A kind of preparation method of five bivalent inactivated vaccine of haemophilus parasuis
CN109954135A (en) Ox A type C.perfringens inactivates toxoid vaccine and preparation method thereof
CN109554420B (en) Clostridium perfringens type B exotoxin and preparation method, toxin production medium and application thereof
RU2428202C1 (en) Associated vaccine against anaerobic enterotoxemia and colibacillosis diarrhea in calves
CN109609418A (en) One plant of erysipelothrix porci and its application
CN110904007B (en) Animal clostridium novyi exotoxin, preparation method thereof, toxigenic culture medium and application
CN101130072B (en) Type A inactivated vaccine for hoof-and-mouth disease
CN109943507B (en) Preparation method and application of veterinary A-type clostridium perfringens toxin
CN107982532B (en) Duck hepatitis A virus antigen-antibody complex vaccine and preparation method thereof
CN113559256B (en) Nocardia immunopotentiator and application thereof in preparation of pig vaccine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant